about
Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyVisual hallucinations in the elderly associated with the use of levodopaPsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Treatment of psychosis and dementia in Parkinson's disease.Prospective study of hallucinations and delusions in Parkinson's diseaseVisual hallucinations in a geriatric psychiatry clinic: prevalence and associated diagnoses.A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's diseaseDopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study.Visual hallucinations in Parkinson's disease: a review and phenomenological survey.The emerging role of clozapine in the treatment of movement disorders.Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?Pathophysiology and treatment of psychosis in Parkinson's disease: a review.Parkinson's psychosis.Psychiatric symptoms in Parkinson's disease.Sleep disorders in Parkinson's disease: the nursing role.Atypical antipsychotics in Parkinson-sensitive populations.An update expert opinion on management and research strategies in Parkinson's disease psychosisBehavioral disturbances in Parkinson's diseasePsychotic symptoms in Parkinson's disease: pathophysiology and management.Psychosis in Parkinson's disease.Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model.Treatment of behavioural symptoms and dementia in Parkinson's disease.Psychotic symptoms in Parkinson's disease. From description to etiology.Hallucinosis in idiopathic Parkinson's disease.Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugs.Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes.Multimodal MRI of the hippocampus in Parkinson's disease with visual hallucinations.Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.Recognition and management of neuropsychiatric complications in Parkinson's disease.New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.Levodopa unresponsive symptoms in Parkinson disease.Hallucinations in Parkinson disease.Behavioral complications of drug treatment of Parkinson's disease.Hallucinations in neurodegenerative diseases.Atypical antipsychotic drugs in the treatment of Parkinson's disease.Anti-allodynic effects of levodopa in neuropathic rats.Sensory symptoms in Parkinson's disease: Clinical features, pathophysiology, and treatment.Current Understanding of Psychosis in Parkinson's Disease.
P2860
Q26738349-7133B74C-B35D-4E0B-A73C-82257057DE3DQ28355598-011EAD7D-11C9-4DDA-9BE5-34A5777FC4C3Q30249553-90634986-C6A7-4FE1-B1B6-E9AD0975AAB7Q30358337-BFB5DAEB-6269-4486-81B2-7DE9650019CAQ30443103-44476D57-DFC8-4B74-9A7F-914DAA03AFF8Q30469831-F96CB953-5EE6-40D1-8289-CFA44386F01BQ30482570-0A4D5049-1056-4656-9BFE-4EBE10079A85Q33465315-7B4CCBEA-DA2A-4ADD-80C7-3DD61CCF6591Q34268928-5D640630-EE40-4BFC-8AA7-23DE8B26D2E8Q34434857-E39FD3A0-410F-4C8B-8E4E-DB7DD51BE1F6Q34566489-E1CD8D55-574A-4713-98BA-1DAA566F9547Q34610593-CB7D7EE6-69D7-4486-AA1A-A5942D797E21Q34610608-B7C5C7B2-12B6-4F9E-A575-8BE107D6063AQ34610632-4BA26AD1-62C9-47C1-BE43-0B76FA7642DCQ34666435-3B576163-B810-4A9D-82B5-E738DDFCC680Q34778880-DBC6B7A7-C176-4498-9BF2-86F3A4A2E639Q34851726-D535BE01-E068-4DB8-B4F1-55EA5AABE681Q35154278-740FFA06-8277-447C-BE94-B3D23AE5F523Q35236819-D69FDF4E-0516-43EE-A200-B99355AEA496Q35779329-829F689A-40FD-4DC9-9831-F3AEF7F8B27BQ35863404-7EC67548-74A3-4C97-853D-BC7E7131CE8CQ35919426-2B7FDEA5-33FF-41B6-BCD0-6F4FBAA5EC7EQ36089350-93D6D788-04AA-447F-87BF-39A1C62D936EQ36184471-C403FBEA-E355-4F16-B4B9-7EC1A9C57CBCQ36317232-11A4D156-E013-4D48-BC33-4BEE1C866171Q36425995-128F28F6-3109-4D16-90F7-60FCA05F8425Q36473516-5EDA3C6D-CDDC-416B-9D3D-44A2ED181334Q36484606-4B6A808C-880A-4F2E-A9AF-7E92C3ACE80EQ36492310-D67B9B6F-052C-466F-B7EC-5BF14BAD9BAEQ36673715-69648632-2533-43CF-9654-C1C4EA15700DQ37021326-B1D0694B-77FB-4182-B602-9A7F04AC20FCQ37168743-221EF45D-F8C3-431F-8318-8638A592F795Q37264473-D0F6EC4A-68CC-4DF1-AE61-C99E98ED7C7CQ37508601-3254F42B-623D-4380-813F-2BD228F5D606Q37771070-C81C6C4A-160E-47F8-809D-8527325D3B3AQ37876971-1FE96FC7-71A2-412C-8874-8407F0B2E56CQ37957772-CF719B6D-F8B6-44DA-8013-27D2681DA2D7Q38453816-94AE25A2-4DF0-45FB-960D-AD6D2F5D0E0FQ38762926-5B90D5D8-7EB7-43CC-950B-B5BEB17DFACBQ38954642-6271C88D-DF90-45D2-98AC-A77B80729949
P2860
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Levodopa-induced psychosis: a kindling phenomenon
@ast
Levodopa-induced psychosis: a kindling phenomenon
@en
Levodopa-induced psychosis: a kindling phenomenon
@nl
type
label
Levodopa-induced psychosis: a kindling phenomenon
@ast
Levodopa-induced psychosis: a kindling phenomenon
@en
Levodopa-induced psychosis: a kindling phenomenon
@nl
prefLabel
Levodopa-induced psychosis: a kindling phenomenon
@ast
Levodopa-induced psychosis: a kindling phenomenon
@en
Levodopa-induced psychosis: a kindling phenomenon
@nl
P2093
P356
P1476
Levodopa-induced psychosis: a kindling phenomenon
@en
P2093
P304
P356
10.1176/AJP.135.6.669
P407
P577
1978-06-01T00:00:00Z